ALDH1A2 and ovarian cancer: First, the cg16391792 site causes defects in ALDH1A2 and leads the low expression of RA. Second, the low expression of RA results in the high levels of IGF. Finally, the high levels of IGF lead to overexpression of AURKA and promote ovarian cancer cell proliferation.